Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.
This study has finished and is no longer accepting participants.
Multiple locations, including TokyoResearchers studied JNS001, tracking side effects to assess long-term safety and tolerability in adults with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including ChibaA Long-term Trial of OPC-34712 in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In Kanto RegionResearchers studied Aripiprazole to find out how it affected psychotic symptoms in children with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Chubu RegionThis study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BelgiumThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanyA Long-Term, Open-Label, Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disorder (Manic or Mixed Episodes) or Schizophrenia
Original registry wording; source language not specified.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanyA Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients With DSM-IV-TR Schizophrenia
This study ended early.
Multiple locations, including Little RockThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In GermanyThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In LatviaAn Open-label, Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
This study has finished and is no longer accepting participants.
Multiple locations, including New HavenWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.